Future Food, Future Medicine, Biorevolution
Louise von Stechow
Epsiode 37: Medical machines get smarter - AI ...

For Episode 37 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow are joined by joined by Julian Beimes, AI in MedTech expert at idalab, to explore how Artificial Intelligence (AI) is transforming the MedTech industry, from AI-powered imaging to smart diagnostics and remote monitoring.

Epsiode 37: Medical machines get smarter - AI in Medtech
Biorevolution, Artificial Intelligence, Future Food
Louise von Stechow
Epsiode 36: We are what we eat – The future of ...

For Episode 36 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow are joined by Lia Carlucci, CEO of Food campus Berlin to discuss the future of food from alternative proteins and personalized nutrition and how the technologies of the BioRevolution, such as genomics and glucose sensing can aid those efforts.

Epsiode 36: We are what we eat – The future of food
Biorevolution, Artificial Intelligence
Louise von Stechow
Epsiode 35: New tech, new talent, new ...

For Episode 35 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow are joined by idalab founder Paul von Bünau to discuss leadership in the age of AI, touching on the potential of AI for biotech and how leaders can adapt processes and help their staff adapt to the new challenges that AI will bring and dive into the question if AI has the potential to make us better leaders.

Epsiode 35: New tech, new talent, new challenges – pharma leadership in the age of AI
Biorevolution
Louise von Stechow
Illuminating the Dark Genome – New Insights ...

For Episode 33 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow are joined by CTO and co-founder of Berlin-based biotech LUCID Genomics, Dr. Hossein Moeinzadeh, to discuss the exciting field of non-coding DNA and how LUCID’s AI algorithm can help make sense of non-coding DNA — and how this could improve diagnoses of rare diseases and beyond.

Illuminating the Dark Genome – New Insights into the Genetic Basis of Disease
Biorevolution, Psychedelics
Louise von Stechow
The biochemistry of the mystical – a ...

After a decades-long hiatus, research on psychedelics as a treatment for psychiatric diseases is experiencing a renaissance—and initial results look promising.

In the newest episode of the BioRevolution podcast, Andreas Horchler and Louise von Stechow discuss the history, the promise, and the risks of psychedelics as treatments for psychiatric diseases with neuroscientist, psychedelics expert, and executive coach Galyna Pidpruzhnykova

The biochemistry of the mystical – a psychedelics renaissance?

Episode 1: Die Biorevolution - Risiken und Versprechen

Die Biorevolution bringt viele neue Technologien, mit großen Versprechungen, aber auch unkalkulierbaren Risiken. In dieser Folge geben Andreas Horchler und Louise von Stechow einen Überblick über die Technologien der Biorevolution und sprechen über die Möglichkeit den Menschen selbst, seine Gene und sein Gehirn zu revolutionieren und über die Unmöglichkeit biologische Agenzien zu kontrollieren, die sich nicht um menschengemachte Regeln, Grenzen und ethische Bedenken kümmern.

Inhalt und Bearbeitung: Louise von Stechow und Andreas Horchler

Bild: unsplash-image-hsPFuudRg5I.jpg

We're doomed we're saved

We’re doomed we’re saved mit Andreas Horchler und Louise von Stechow – Vater und Tochter, er Journalist, sie Biologin, sprechen über die Technologien der Biorevolution. Können Gentechnik, Synthetische Biologie und Künstliche Intelligenz die Menschheit vor Krankheit, Klimawandel und Überbevölkerung retten, oder sind diese Technologien der erste Schritt ihres Untergangs?